Mu‐En Wang
Impact in
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
-
- Cancer, Lipids, and Metabolism
Papers in
-
- Ubiquitin and proteasome pathways 1
- FOXO transcription factor regulation 1
-
- Autophagy in Disease and Therapy 3
- Co-authors
- Chih‐Hsien Chiu (7 shared papers)Yi‐Chen Chen (2 shared papers)I-Shu Chen (1 shared paper)Shu‐Chen Hsieh (1 shared paper)Brijesh Kumar Singh (2 shared papers)De‐Shien Jong (4 shared papers)Paul M. Yen (2 shared papers)Leang‐Shin Wu (3 shared papers)
- Journals
- Scientific Reports (3 papers)Vaccines (1 paper)The Journal of Pathology (1 paper)BioMed Research International (1 paper)PeerJ (1 paper)
- Partner nations
- United StatesTaiwanSingapore
In The Last Decade
Mu‐En Wang
13 papers receiving 341 citations
Peers
Comparison fields: 5 of 62
- Molecular Medicine 38
- Cancer Research 56
- Hepatology 28
- Pharmacology 25
- Epidemiology 85
Countries citing papers authored by Mu‐En Wang
This map shows the geographic impact of Mu‐En Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mu‐En Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mu‐En Wang more than expected).
Fields of papers citing papers by Mu‐En Wang
This network shows the impact of papers produced by Mu‐En Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mu‐En Wang. The network helps show where Mu‐En Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Mu‐En Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 99 | |
| 2 | 2023 | 73 | |
| 3 | 2015 | 42 | |
| 4 | 2017 | 38 | |
| 5 | 2016 | 23 | |
| 6 | 2019 | 17 | |
| 7 | 2023 | 12 | |
| 8 | 2017 | 12 | |
| 9 | 2022 | 9 | |
| 10 | 2021 | 8 | |
| 11 | 2024 | 6 | |
| 12 | 2024 | 4 | |
| 13 | 2023 | 2 | |
| 14 | 2025 | 0 |
About Mu‐En Wang
Mu‐En Wang is a scholar working on Molecular Biology, Epidemiology, Pulmonary and Respiratory Medicine, Cancer Research and Pharmacology, having authored 14 papers that have together received 345 indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (3 papers), Cannabis and Cannabinoid Research (2 papers), Prostate Cancer Treatment and Research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Muscle metabolism and nutrition (1 paper), Ubiquitin and proteasome pathways (1 paper), Ferroptosis and cancer prognosis (1 paper) and FOXO transcription factor regulation (1 paper). The work is most often cited by research in Molecular Medicine (38 citations), Cancer Research (56 citations), Hepatology (28 citations), Pharmacology (25 citations) and Epidemiology (85 citations). Mu‐En Wang has collaborated with scholars based in United States, Taiwan and Singapore. Frequent co-authors include Chih‐Hsien Chiu, Yi‐Chen Chen, I-Shu Chen, Shu‐Chen Hsieh, Brijesh Kumar Singh, De‐Shien Jong, Paul M. Yen, Leang‐Shin Wu, Jiaoti Huang and Lei Li. Their work appears in journals such as Scientific Reports, Vaccines, The Journal of Pathology, BioMed Research International and PeerJ.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.